125 related articles for article (PubMed ID: 138480)
1. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.
Buroker T; Samson M; Correa J; Fraile R; Vaitkevicius VK
Cancer Treat Rep; 1976 Sep; 60(9):1277-9. PubMed ID: 138480
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases.
Allen-Mersh TG; Glover C; Fordy C; Mathur P; Quinn H
Eur J Surg Oncol; 2000 Aug; 26(5):468-73. PubMed ID: 11016468
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
8. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
10. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine.
Davies MM; Johnston PG; Kaur S; Allen-Mersh TG
Clin Cancer Res; 1999 Feb; 5(2):325-8. PubMed ID: 10037181
[TBL] [Abstract][Full Text] [Related]
11. [Locoregional chemotherapy of hepatic metastases of colorectal cancer].
Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
14. On the differential affinities of two anticancer analogues to their target.
Holl E; Zänker KS; Lange J; Siewert JR
Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
[TBL] [Abstract][Full Text] [Related]
15. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
Barber FD; Mavligit G; Kurzrock R
Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatic metastases with a combination of hepatic artery infusion chemotherapy and external radiotherapy.
Herbsman H; Hassan A; Gardner B; Harshaw D; Bohorquez J; Alfonso A; Newman J
Surg Gynecol Obstet; 1978 Jul; 147(1):13-7. PubMed ID: 149383
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
Martin RC; Scoggins CR; McMasters KM
J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
